Holly Shiels

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom.

Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom.

Action Medical Research is a charity organization that funds medical research to help sick and disabled babies, children, and young people. The private company is based in Horsham, UK. The British company has been funding medical breakthroughs for 70 years and has helped to beat polio, fight meningitis, prevent stillbirths, and develop ultrasound scanning in pregnancy. The company funds a wide range of cutting-edge medical research most likely to deliver real benefit in pregnancy and to babies, children, and young people. The company was founded in 1952 by Duncan Guthrie. The CEO is Julie Buckler.

Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB.

Part of Advanced Instruments LLC, Solentim Ltd. is a British company that specializes in workflows for antibody and cell-based therapies. The company is based in Wimborne, UK. The company's technologies enable the isolation, growth, and characterization of high-value cells, while their data-driven platform enables smarter decisions earlier in the process. The CEO of the company is Mark Truesdale. Solentim was acquired by Advanced Instruments LLC on September 30, 2021 for $333.83 million.